Status:
RECRUITING
Monitoring Response to NAC and Prediction of pCR in Breast Cancer Patients Using Optical Imaging
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
Politecnico di Milano
Conditions:
Breast Cancer Female
Chemotherapy Effect
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Neoadjuvant chemotherapy (NAC) is the first line treatment for locally advanced breast cancer (BC). Besides making breast conserving surgery feasible, its main aim is to achieve a pathological complet...
Detailed Description
In this study, an accurate, reliable, non-invasive modality with good patient tolerance will be tested to predict response to NAC in order to tailor the medical and surgical treatment. The aim of thi...
Eligibility Criteria
Inclusion
- Women above 18 years of age
- Women with a recent diagnosis of breast cancer candidate for neoadjuvant chemotherapy
- Women willing to give informed consent
Exclusion
- Subject is pregnant or breastfeeding
- Subject is unable or unwilling to give informed consent
- Previous surgery of the same breast
- Presence of distant metastasis
- Breast implants
Key Trial Info
Start Date :
January 27 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04767659
Start Date
January 27 2020
End Date
August 30 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Raffaele
Milan, Italy, 20132